Silver Book Fact

An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment and caregiver-support programs; the greatest benefits with a combination of both.

Weimer, David L, and Mark A Sager. Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes. Alzheimers Dement. 2009; 5(3): 215-26. http://www.alzheimersanddementia.com/article/S1552-5260(09)00029-6/abstract

Reference

Title
Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes
Publication
Alzheimers Dement
Publication Date
2009
Authors
Weimer, David L, and Mark A Sager
Volume & Issue
Volume 5, Issue 3
Pages
215-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, every $1 spent on Alzheimer’s research would save Medicare $10 by 2015 and $25 by 2025.  
  • According to the Pharmaceutical Research and Manufacturers of America, because of medical research, the number of Americans with Alzheimer’s could decrease by 3 million in 2025.  
  • An Alzheimer’s treatment breakthrough that slowed disease progression and began to show effects in 2015, would reduce Medicaid costs for people with the disease by $62 billion–from the expected $178…  
  • More Effective Treatment of Alzheimer’s Disease Could Save Billions: Combined Medicare and Medicaid savings from effective treatment of Alzheimer’s diease  
  • A medicine is in development that aims to prevent or reverse Alzheimer’s disease progression by using a human monoclonal antibody specifically designed to remove beta amyloid protein from the brain.